Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Cipla Ltd. Interim / Quarterly Report 2019

Dec 3, 2019

59275_rns_2019-12-03_15fe8aa7-ddc7-4dd2-89db-64afa21c4c0e.pdf

Interim / Quarterly Report

Open in viewer

Opens in your device viewer

3rd December, 2019

  • (1) BSE Ltd Listing Department Phiroze Jeejeebhoy Towers, Dalal Street, Mumbai - 400 001
  • (2) National Stock Exchange of India Ltd Listing Department Exchange Plaza, 51 h floor, Plot no. C/1, G Block, Sandra Kurla Complex, Sandra (East), Mumbai - 400 051

Scrip Code: 500087

Scrip Code: CIPLA

(3) SOCIETE DE LA BOURSE DE LUXEMBOURG Societe Anonyme 35A Boulevard Joseph II, L-1840 Luxembourg

Sub: Disclosure of related party transactions for the half year ended 30th September, 2019

Dear Sir/Madam,

Pursuant to Regulation 23(9) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed disclosure of related party transactions on a consolidated basis, in the format specified in the accounting standards for the half year ended 3Q1 hSeptember, 2019.

This disclosure is also being uploaded on the website of the Company i.e. www.cipla.com.

This is for your information and record.

Thanking you,

Rajendra Chopra Company Secretary

Prepared by: Pratiksha Mangaonkar

Ud.

Information on related party transactions as required by lnd AS-24 - 'Related Party Disclosures' are given below: list of related parties A. Associate Stempeutics Research Private Limited Avenue Therapeutics Inc. Brandmed (Pty} Ltd. (w.c.f. 24th April, 2019}

B. Key Management Personnel

Ms. Sam ina Vaziralli- Executive Vice-Chairperson Mr. Umang Vohra- Managing Director and Global Chief Executive Officer Mr. Kedar Upadhye- Global Chief Financial Officer Dr. Raghunath an Ananthanarayanan- President and Global Chief Operating Officer

C. Non-Executive Chairman & Non-Executive Vice Chairman

Dr. Y.K. Hamied, Chairman Mr. M.K. Hamied, Vice Chairman

D. Non Executive Directors

Mr. Ashok Sinha Mr. Adil Zainulbhai Ms. Punita Lal Ms. Naina Lal Kidwai Mr. Peter Lankau (upto 30th June, 2019} Dr. Peter Mugyenyi Mr. S Radhakrishnan

E. Entities over which Key Management Personnel are able to exercise significant influence Cipla Foundation

Chest Research Foundation (formerly known as Hamied Foundation upto 14th October, 2019} Cipla Cancer and AIDS Foundation

F. Trust over which entity has control/significant influence

Cipla Limited Employees Provident Fund Cipla Limited Employees Gratuity Fund Cipla Employees Stock Option Trust Cipla Health Employees Stock Option Trust

Cipla Ud.

~in Crores
Particulars For the half year ended
th 30 September, 2019
Remuneration (Including sitting fees)*A.
Dr. Y.K. Hamied 1.01
Mr. M.K. Hamied 1.04
Ms. Samina Vaziralli 3.36
Mr. Umang Vohra 7.23
Mr. S Radhakrishnan 1.06
Mr. Kedar Upadhye 1.93
Mr. Ashok Sinha 0.24
Mr. Adil Zainulbhai 0.23
Ms. Punita Lal 0.21
Ms. Naina Lal Kidwai 0.23
Mr. Peter Lankau 0.17
Dr. Peter Mugyenyi 0.40
Dr. Raghunathan Ananthanarayanan 6.22
23.33

* Expenses towards gratuity and leave encashment prov1s1ons are determined actuarially on an overall company basis at the end of each year and accordingly have not been considered in the above information

Testing and analysis charges paidB.
Stempeutics Research Private Limited 0.98
0.98
Contribution to provident fund and other fundC.
Cipla Limited Employees Provident Fund 20.91
20.91
Donations givenD.
Cipla Foundation 18.42
18.42
Rent receivedE.
Dr. Y.K. Hamied (Rs. 10,020/-) 0.00
0.00
Reimbursement of operating/other expensesF.
Stempeutics Research Private Limited 0.04
0.04
Investment made during the periodG.
Brandmed (Pty) Ltd. 31.61
31.61

ltd.

Regd. Office- Ciplo House, Peninsula Business Park, Ganpatroo Kadom Marg, Lower Parel, Murnbai ~00013, India. p •'II 22 21,826000 F •91 22 21,826120 W www.cipla.corn E-Mail [email protected] Corporate Identity Number L24239MHI'I35PLC002380

~in Crores
For the half year ended
Particulars th 30 September, 2019
Payable to Key Management PersonnelH.
Dr. Y.K. Hamied 1.00
Mr. M.K. Hamied 1.00
Ms. Samina Vaziralli 1.15
Mr. Umang Vohra 2.00
Mr. 5 Radhakrishnan 1.00
Mr. Kedar Upadhye 0.48
Mr. Ashok Sinha 0.20
Mr. Adil Zainulbhai 0.18
Ms. Punita Lal 0.18
Ms. Naina Lal Kidwai 0.18
Mr. Peter Lankau 0.10
Dr. Peter Mugyenyi 0.21
Dr. Raghunathan Ananthanarayanan 1.38
9.06
Contribution payable to provident fundI.
Cipla Limited Employees Provident Fund 3.45
3.45
Payable to gratuity fundJ.
Cipla Limited Employees Gratuity Fund 21.63
21.63
Dividend PaidK.
Dr. Y.K. Hamied 49.19
Mr. M.K. Hamied 10.37
Ms. Samina Vaziralli 5.37
Mr. Umang Vohra 0.06
Mr. 5 Radhakrishnan 0.03
Mr. Kedar Upadhye 0.01
65.03

Cipla Ud.

Regd. Oftice- Cipla Hause, Peninsula Business Park, Ganpatraa Kadam Marg, Lower Porel, lvfurnbai 00013, India. p •91 22 21,826000 F •91 22 21,826120 W www ciplo com E-N ail [email protected] Corporate Identity Number L2239MH1935PLC002380